President Donald Trump announced on May 1 that Medicare patients will soon be able to obtain coverage for weight-loss drugs for $50 per month.
Speaking at an event in Florida, Trump said the coverage for the weight-loss and diabetes medications will begin in July, referencing drugs that contain semaglutide, a GLP-1 receptor agonist.





